Identification of Actionable Gene Variants in Pulmonary Large-Cell Neuroendocrine Carcinoma: A Real-World Analysis of a Polish Cohort
International Journal of Molecular Sciences · 24.03.2026 · 27 (7) · 2939
DOI: 10.3390/ijms27072939 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.03.2026. Verfasst von Adam Szpechcinski und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Clinical Immunology, The Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Lung Neoplasms, Carcinoma, Large Cell. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Tuberculosis and Lung Diseases in Warsaw, Poland.
Abstract (Originalsprache)
Pulmonary large-cell neuroendocrine carcinoma (LCNEC) is a rare lung malignancy characterized by an aggressive clinical course and an unfavorable prognosis. Next-generation sequencing (NGS) has revealed that LCNECs exhibit molecular features resembling either small-cell lung carcinoma (SCLC-like LCNEC) or non-small cell lung carcinoma (NSCLC-like LCNEC). This study aimed to characterize the incidence of actionable gene variants in a retrospective cohort of LCNEC patients using a targeted NGS approach. Microscopic diagnosis was established according to the 2021 World Health Organization (WHO) classification using a standard immunohistochemical (IHC) panel. In total, 216 LCNEC tumor samples were analyzed for molecular variants in 17 genes using the RNA-based Archer FusionPlex Lung NGS assay (Integrated DNA Technologies, USA) and the MiSeq platform (Illumina, USA)—an algorithm utilized for routine NSCLC diagnosis. Overall, 46 variants were identified in 46/216 (21.3%) tumor samples, with 28/216 (13%) LCNECs harboring at least one actionable molecular variant potentially targetable by registered or investigational agents. KRAS variants (5%; including G12C at 2%) and PIK3CA variants (5%) were the most prevalent, followed by RET single-nucleotide variants (3%), uncommon EGFR variants (1%), and BRAF class II and III variants (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genetics and Clinical Immunology, The Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
- Department of Pathology, The Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
- Clinical Department of Thoracic Surgery, The Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
- Clinical Department of Thoracic Tumors, The Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
- Outpatient Clinic, The Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
ORCID-Profile: Adam Szpechcinski, Magdalena Pelc, Urszula Lechowicz, Joanna Moes-Sosnowska, Elzbieta Podgorska, Mateusz Polaczek, Joanna Chorostowska-Wynimko
Förderung
- Institute of Tuberculosis and Lung Diseases in Warsaw, Poland
Zitieren
APA
Szpechcinski, A., Pelc, M., Lechowicz, U., Szolkowska, M., Moes-Sosnowska, J., Rudzinski, P., Wojda, E., Skronska, P., Podgorska, E., Maszkowska-Kopij, K., Polaczek, M., Orlowski, T., Langfort, R., & Chorostowska-Wynimko, J. (2026). Identification of Actionable Gene Variants in Pulmonary Large-Cell Neuroendocrine Carcinoma: A Real-World Analysis of a Polish Cohort. International Journal of Molecular Sciences, 27(7), 2939. https://doi.org/10.3390/ijms27072939
Vancouver
Szpechcinski A, Pelc M, Lechowicz U, Szolkowska M, Moes-Sosnowska J, Rudzinski P, et al. Identification of Actionable Gene Variants in Pulmonary Large-Cell Neuroendocrine Carcinoma: A Real-World Analysis of a Polish Cohort. International Journal of Molecular Sciences. 2026;27(7):2939. doi:10.3390/ijms27072939
BibTeX
@article{Szpechcinski2026,
author = {Szpechcinski, Adam and Pelc, Magdalena and Lechowicz, Urszula and Szolkowska, Malgorzata and Moes-Sosnowska, Joanna and Rudzinski, Piotr and Wojda, Emil and Skronska, Paulina and Podgorska, Elzbieta and Maszkowska-Kopij, Krystyna and Polaczek, Mateusz and Orlowski, Tadeusz and Langfort, Renata and Chorostowska-Wynimko, Joanna},
title = {Identification of Actionable Gene Variants in Pulmonary Large-Cell Neuroendocrine Carcinoma: A Real-World Analysis of a Polish Cohort},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {2939},
doi = {10.3390/ijms27072939}
}
EUVIMED